PONTE VEDRA BEACH, Fla., June 4, 2021—RedDress, a privately held, Israel and U.S. based wound care company, today announced that it will showcase ActiGraft®’s advanced wound care technology this summer at the FPMA Conference in Bonita Springs, FL from June 10-12, 2021. The Florida Podiatric Medical Association (FPMA) is a leading voice in the podiatric medical field and strives to promote the advancement of podiatric medicine and surgery.

 

RedDress developed ActiGraft as a simple, effective, and cost-efficient treatment for hard-to-heal chronic wounds, including diabetic foot ulcers, pressure injuries, venous ulcers, traumatic wounds, post-surgical wounds, and skin tears. ActiGraft is an innovative wound solution that uses a patient’s own blood to create an autologous blood clot which acts as a protective covering to the wound and supports the body’s natural healing process.

 

“We are pleased to participate in this year’s FPMA Conference and have the opportunity to present both a lecture and a product theatre to showcase the innovative ActiGraft technology” said Rhonda Smith, National Sales Director USA. “ActiGraft is expected to see significant growth and adoption in the podiatric field. We are confident ActiGraft will continue to improve patient outcomes as a safe and highly effective wound solution that will produce a lasting impact on the care and treatment of hard-to-heal wounds.”

 

Attendees can visit RedDress representatives at Booth #26 or attend the following sponsored activities to meet the RedDress team and learn more about ActiGraft and its healing technology:

 

 

RedDress Sponsored Activities –

 

Podium Poster Presentation

 

  • “Proposed Mechanism of Action of Topically Applied Autologous Blood Clot: A Quintessential Cellular and Tissue Based Therapy”

The presentation will highlight the safety and efficacy of ActiGraft and discuss the technology behind how ActiGraft works to support the healing of wounds.

Friday, June 11, 2021, 11:00am-12:00pm

Presenter: Dr. Robert Snyder, DPM, MSc, CWS, FFPM RCPS

 

Product Theatre

 

  • Recreating the Natural Wound Healing Environment”

The product theatre will provide an overview of RedDress’ innovative wound solution, ActiGraft including a discussion on features, benefits, case studies, and more.

Friday, June 11, 2021, 2:30-3:30pm

Presenter: Dr. Martin Schnell, MD

 

 

About RedDress®­­

RedDress (www.reddressmedical.com) is a privately held, Israel-based company with a U.S. subsidiary, RedDress Inc., located in Ponte Vedra Beach, Florida. Founded in 2009 with the goal of developing more effective, natural, and economically viable treatments for chronic wounds, RedDress is committed to improving the health and lives of patients around the world with its latest innovation – ActiGraft.

 

Press and Media Inquiries:

Alessandra Lalli, RedDress

alalli@reddressmedical.com

 

Investor Inquiries:

Russ Lalli, RedDress

rlalli@reddressmedical.com

crossmenu